The Differential Manifestation of Alcohol Withdrawal Symptoms Related to GABAAalpha6 Polymorphism.
- Author:
Doug Hyun HAN
1
;
Jung Eun CHOI
;
Byung Young LEE
;
Young Hoon KIM
;
Hae Won KIM
;
Hye Kyung LEE
Author Information
1. Department of Psychiatry, Chun-cheon National Hospital, Chun-cheon, Korea.
- Publication Type:Original Article
- Keywords:
GABA receptor;
Benzodiazepine;
Alcohol withdrawal;
Alcohol dependence;
Genetic polymorphism
- MeSH:
Alcoholism;
Alleles;
Anxiety;
Benzodiazepines;
Dihydroergotamine;
gamma-Aminobutyric Acid;
Headache;
Humans;
Inpatients;
Polymorphism, Genetic;
Receptors, GABA;
Substance Withdrawal Syndrome*;
Tremor
- From:Journal of Korean Neuropsychiatric Association
2005;44(2):191-197
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
INTRODUTION: The gamma-aminobutyric acid type A (GABAA) receptor is an important pharmacological target of alcohol. The phamacological characteristics of the receptor are largely determined by its subunit composition. Compared with all other alpha subtypes, the alpha6- containing receptors are more sensitive to GABA and less sensitive to benzodiazepines. The purpose of this study was to address a role for GABAAalpha6 receptor subunit gene in the development of alcohol dependence. The differential manifestation of alcohol withdrawal symptoms related to GABAAalpha6 polymorphism in patients treating with benzodiazepines was also examined. METHODS: Eighty-seven inpatients with alcohol dependence, and sixty healthy controls were evaluated using CIWA-Ar scale. Each patient was genotyped for GABAAalpha6 subunit. Association between GABAAalpha6 polymorphism and severity of withdrawal symptom were determined. RESULTS: No significant difference was found in GABAAalpha6 receptor genetic type and allelic distribution between the alcohol dependent and control subject. Tremor was more severe in CC than TT type. TT type had higher degree of anxiety, agitation and headache than CC type. The GABAAalpha6 C allele increased the average score of tremor significantly, and T allele increased that of agitation. CONCLUSION: The results suggested that GABAAalpha6 genetic polymorphism was not associated with alcohol dependence and with severity of alcohol withdrawal symptoms. But in benzodiazepine treated patients, GABAAalpha6 polymorphism and allelic type show the difference in severity of each withdrawal symptom. These differences of severity are partly responsible for the unique pharmacological properties associated with the GABAAalpha6 subunit.
